logo-education
0370 270 6000

already registered?

Please sign in with your existing account details.

need to register?

Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.

Privacy statement - Terms and conditions

Forgotten your password?

Rotherham report: impact on education

27 August 2014

The independent inquiry into child sexual exploitation (CSE) in Rotherham was published yesterday and whilst education was not singled out for particular criticism, the report is likely to lead to changes in the way schools identify and manage CSE.

CSE will now be higher on the safeguarding agenda. As a result, additional training will be required for safeguarding professionals in schools and we are very likely to see new guidance to replace the four page 2012 guidance from the DfE, which itself refers back to a 96 page guidance document from 2009.

The report made 15 recommendations and whilst education is not specifically referred to, recommendations 5, 6 and 8 – all dealing with the multiagency membership and effective working of joint CSE teams – will impact on schools soon.

Sex education may also be in need of an overhaul to ensure the risks of CSE are adequately covered.

Related opinions

Does the move into Step 4 mean the ending of Covid-19 restrictions within schools?

With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.

View blog

Advocacy in Action: Female Genital Mutilation Protection Orders (FGMPO)

The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.

View blog

Responsibilities towards students identifying as non-binary

Our top tips for supporting transgender and non-binary pupils.

View blog

Schools face scrutiny over Covid-19 vaccinations for children

On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.

View blog

Mailing list sign up

Select which mailings you would like to receive from us.

Sign up